Hikma Pharmaceuticals PLC

Hikma Posts Solid H1 Results, Reaffirms Strong Growth Outlook For 2025

07 авг 2025 00:32:12 Источник NASDAQ US Markets

Hikma Pharma Announces Launch Of Morphine Sulfate Injection In The US

14 июл 2025 02:25:12 Источник NASDAQ US Markets

Bio-Thera Solutions And Hikma Pharma Say FDA Approved STARJEMZA Injection

26 май 2025 23:43:27 Источник NASDAQ US Markets

Hikma Pharma Reaffirms FY25 Guidance Amid Strong Start

24 апр 2025 00:54:25 Источник NASDAQ US Markets

Axsome Settles Patent Litigation With Hikma Related To Sunosi - Quick Facts

05 мар 2025 04:55:56 Источник NASDAQ US Markets

Hikma Pharma Inks Exclusive Commercial Deal With Emergent BioSolutions For KLOXXADO Nasal Spray 8 Mg

14 янв 2025 05:49:06 Источник NASDAQ US Markets

Hikma Pharma Extends Recall Of Acetaminophen Injection

23 июл 2024 00:11:57 Источник NASDAQ US Markets

Hikma Pharma To Acquire Parts Of Xellia Pharma's US Finished Dosage Form Business And Assets

16 июн 2024 23:45:01 Источник NASDAQ US Markets

Collegium Pharma Partners With Hikma For Authorized Generics Of Nucynta In US

29 апр 2024 06:07:49 Источник NASDAQ US Markets

Hikma Pharma FY Profit Increases

22 фев 2024 00:52:27 Источник NASDAQ US Markets

Hikma Pharma Launches Pain Relief Injection COMBOGESIC IV In US

05 фев 2024 04:48:52 Источник NASDAQ US Markets

Guardant Health, Hikma To Offer Cancer Screening & Genomic Profiling Tests In Middle East & Africa

08 янв 2024 00:35:52 Источник NASDAQ US Markets

Hikma Pharmaceuticals (LSE:HIK) Price Target Increased by 9.63% to 2,311.15

31 авг 2023 22:51:58 Источник NASDAQ Stocks

Hikma Pharma H1 Profit Down, Revenues Up; Lifts FY23 Forecast For Generics

03 авг 2023 00:46:32 Источник NASDAQ US Markets

Barclays Reiterates Hikma Pharmaceuticals (LSE:HIK) Equal Weight Recommendation

04 май 2023 17:30:46 Источник NASDAQ Stocks

Hikma Pharma Appoints Riad Mishlawi As CEO, Effective Sept. 1

11 апр 2023 23:25:53 Источник NASDAQ US Markets

Hikma Pharma FY22 Results Down, Lifts Dividend; Says Confident Of FY23 Growth; Stock Up

23 фев 2023 01:10:05 Источник NASDAQ US Markets

Hikma accuses Amarin of suppressing generic versions of heart pill

22 фев 2023 14:13:30 Источник NASDAQ US Markets

Hikma Pharma Launches Authorized Generic Version Of Xyrem In U.S.

03 янв 2023 00:15:34 Источник NASDAQ US Markets

Hikma Pharma Says Not Signed Licensing Agreement With Opiant Pharma

29 апр 2022 20:58:14 Источник NASDAQ US Markets